source
- Opinion: STAT+: Medicare’s new RAPID pathway is a breakthrough for adults. Children are still waiting“The pediatric and orphan pipeline is already the smallest, slowest, and least capitalized segment of the device industry,” writes Kolaleh Eskandanian.STAT · 2mo ago↗ source
- Why we left the FDA: Six former officials share their storiesIn this week's STATus Report, hear from six former FDA officials on why they left the agency.STAT · 2mo ago↗ source
- Odyssey, on second try, snags $279M in an IPOAfter withdrawing its initial filing last year, the immune drugmaker rebounded and added to a recent run of sizable new biotech stock offerings — while boosting its haul even higher through a concu…BioPharma Dive · 2mo ago↗ source